Stent Retriever Versus Contact Aspiration in Irregular Occlusion Phenotype

Last updated: February 27, 2024
Sponsor: Hopital Foch
Overall Status: Active - Recruiting

Phase

N/A

Condition

Stroke

Cerebral Ischemia

Treatment

contact aspiration thrombectomy

stent retriever thrombectomy

Clinical Study ID

NCT05595876
2019_0017
  • Ages > 18
  • All Genders

Study Summary

Patients with a clinico-neuroradiological mismatch pattern shown on the magnetic resonance imaging/Computed Tomography in the acute phase of stroke are more likely to benefit from reperfusion, are suitable candidates for endovascular therapy, and have a better clinical prognosis.

The ASTER Trial showed similar results between stent-retrievers and contact aspiration concerning the recanalization grade in anterior circulation occlusions. However, we still observe late and futile recanalizations, secondary either to extended ischemic lesions at baseline, long-time procedures or intraprocedural complications. The First Pass Effect that is the complete/nearly complete recanalization after the first maneuver, independently on the technique used, has been strongly associated with better clinical outcomes . In a recent paper we proposed a novel approach to identify those cases that could be treated with a specific technique (stent-retriever) with higher chances to achieve a complete or nearly complete recanalization, with lower procedure times and lower complication rates. This approach is focused on the identification of a regular or irregular phenotype of the occlusion site in patients with an M1-Middle Cerebral Artery occlusion. The phenotype is defined as "regular" whether the profile of the occlusion is abruptly cut without any irregularity and as "irregular" if any irregularity of the profile of the occlusion is observed. One of the hypotheses that could explain these results could be related to the composition of the clot : a soft and less organized clot could be more easily flattened by the pulsatile flow and therefore determine a regular aspect of the occlusion. A more solid and organized clot would, on the contrary, maintain an irregular profile because it would not be flattened by the blood flow and the contrast medium could highlight the irregularities of the proximal face of the clot.

The latter could be a favorable target for the use of a stent-retriever since the interaction between a solid clot and the struts of the stent could increase the chance to retrieve the clot. Therefore, we propose this randomized controlled trial to assess the superiority of stent-retrievers compared to contact aspiration in the treatment of irregular phenotype occlusions of the M1-Middle Cerebral Artery.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Age ≥ 18 years
  • M1-Middle Cerebral Artery occlusion
  • Eligible for mechanical thrombectomy: groin puncture performed within 24 hours fromthe first symptoms or from the last time the patient was seen normal.
  • Presence of a mismatch on Magnetic resonance imaging MRI or CT (computed tomography)scan
  • Baseline mRS <2
  • Irregular occlusion phenotype on the first angiographic run
  • Informed consent obtained from the patients/his proxy or following an emergencyprocedure
  • Being covered by a national health insurance

Exclusion

Exclusion Criteria:

  • Isolated M2 occlusions
  • Clinical history, past imaging or clinical judgment suggesting underlying intracranialstenosis
  • Severe contrast medium allergy or absolute contraindication to use of iodinatedproducts
  • Patients with severe or fatal comorbidities that will likely prevent improvement orfollow-up, or that will render the procedure unlikely to benefit the patient
  • Angiographic evidence of carotid dissection or tandem cervical occlusion or stenosisrequiring treatment
  • Pregnancy (urine or serum beta HCG test for women of child-bearing potential)
  • Patient benefiting from a legal protection (guardianship or curatorship)
  • Being deprived of liberty

Study Design

Total Participants: 356
Treatment Group(s): 2
Primary Treatment: contact aspiration thrombectomy
Phase:
Study Start date:
December 19, 2022
Estimated Completion Date:
November 01, 2025

Study Description

Statistical analyses will be independently performed by the Biostatistics Department of University of Lille under the responsibility of Julien Labreuche. Data will be analyzed using the SAS software (SAS Institute Inc, Cary, NC, USA). A detailed statistical analysis plan will be written and finalized prior to the database lock. Baseline characteristics will be described for each group. Quantitative variables will be expressed as mean (standard deviation) or median (interquartile range) for non-Gaussian distribution. Qualitative variables will be expressed as frequencies and percentages. Normality of distribution will be assessed graphically and using the Shapiro-Wilk test. All applicable statistical tests will be 2-sided and no correction for multiple comparisons will be applied; all secondary objectives will be considered as exploratory and results were reported with only effect size estimates with their confidence intervals (CIs). All CIs presented will be 95%CI and 2-sided. The final report will be written, based on the CONSORT statement recommendations.

Connect with a study center

  • Chu Bordeaux

    Bordeaux,
    France

    Site Not Available

  • CHU Montpellier

    Montpellier,
    France

    Site Not Available

  • Chru Nancy

    Nancy,
    France

    Active - Recruiting

  • Chu Nantes

    Nantes,
    France

    Active - Recruiting

  • APHP - Pitié Salpêtrière

    Paris,
    France

    Active - Recruiting

  • Fondation Adolphe de Rothschild

    Paris,
    France

    Active - Recruiting

  • CHU de Reims

    Reims,
    France

    Active - Recruiting

  • Hôpital FOCH

    Suresnes,
    France

    Active - Recruiting

  • CHU de Tours

    Tours,
    France

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.